News on Emtriva from BioPortfolio.com http://www.BioPortfolio.com Consolidated Emtriva news from BioPortfolio.com Tue, 09 Feb 2010 22:54:37 GMT en Less resistance with FTC than 3TC when combined with tenofovirhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030678&HITNO=0&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030678&THISHREF=http://c.moreover.com/click/here.pl%3fz2533758995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030678&HITNO=0&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030678&THISHREF=http://c.moreover.com/click/here.pl%3fz2533758995%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAidsmap: Epidemiology of HIV/HBV Coinfection in a U.S. Military Cohorthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980349&HITNO=1&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980349&THISHREF=http://c.moreover.com/click/here.pl%3fz2506335833%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980349&HITNO=1&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980349&THISHREF=http://c.moreover.com/click/here.pl%3fz2506335833%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHIV and Hepatitis.com: Gilead Fourth Quarter Profit Rises 43% on Atripla Saleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980164&HITNO=2&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980164&THISHREF=http://c.moreover.com/click/here.pl%3fz2506246289%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980164&HITNO=2&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980164&THISHREF=http://c.moreover.com/click/here.pl%3fz2506246289%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Earnings Preview: Gilead Sciences, Inc. (NASDAQ: GILD)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972466&HITNO=3&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972466&THISHREF=http://c.moreover.com/click/here.pl%3fz2502432776%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972466&HITNO=3&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972466&THISHREF=http://c.moreover.com/click/here.pl%3fz2502432776%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comI Stock Analyst: Gilead 4Q Profit Rises 43 Percent on Atripla Saleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969044&HITNO=4&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969044&THISHREF=http://c.moreover.com/click/here.pl%3fz2500658565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969044&HITNO=4&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969044&THISHREF=http://c.moreover.com/click/here.pl%3fz2500658565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Gilead 4Q profit rises 43 percent on Atripla saleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966406&HITNO=5&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966406&THISHREF=http://c.moreover.com/click/here.pl%3fz2499016494%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966406&HITNO=5&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966406&THISHREF=http://c.moreover.com/click/here.pl%3fz2499016494%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Gilead Sciences' 3-in-1 HIV treatment became its top drug in 4Q as Atripla sales rose 50 pcthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966527&HITNO=6&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966527&THISHREF=http://c.moreover.com/click/here.pl%3fz2499066746%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966527&HITNO=6&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966527&THISHREF=http://c.moreover.com/click/here.pl%3fz2499066746%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDCExaminer.com: Gilead 4Q profit rises 43 percent on Atripla saleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966485&HITNO=7&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966485&THISHREF=http://c.moreover.com/click/here.pl%3fz2499045413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966485&HITNO=7&MSIZE=8&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Emtriva&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966485&THISHREF=http://c.moreover.com/click/here.pl%3fz2499045413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comForbes.com: